The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2019 | MR Linac: benefits, usage & research collaborations
The MR Linac is an exciting new development in the field of radiotherapy. Here, Fiona McDonald, MA, MBBS, MRCP, FRCR, MD, of the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK, discusses it’s benefits, current usage in the UK and research collaborations with centers abroad. This interview took place at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.
